A Culture of Innovation: A Q&A with Jeffrey S. Hatfield, CEO of Vitae Pharmaceuticals
In this Q&A with Lisa Walkush, principal with Grant Thornton LLP's Life Sciences practice, CEO of Vitae Pharmaceuticals Jeffrey S. Hatfield covers his emerging company and the changes to the industry.